ELISA KITS FOR SARS-COV-2 / COVID-19

 Understanding the novel coronavirus and curbing the spread of COVID-19 requires a diverse array of reagents. One of the most important tools is Enzyme-Linked Immunosorbent Assays (ELISAs), qualitative and quantitative tests for the detection of different molecules. In the case of SARS-COV-2 and COVID-19, these kits detect patient immunoglobulins against viral proteins to assess immunity. Emerging evidence suggests that hyperactivity of the immune system after SARS-COV-2 infection can trigger excessive release of cytokines such as IL-6, TNF alpha and IFN gamma. This rapid immune escalation is called the cytokine storm syndrome and can lead to severe lung damage and death.

Proteintech offers well-validated and highly sensitive indirect and sandwich ELISA kits for detecting immunoglobulins against SARS-CoV-2 proteins and the cytokines involved in cytokine release syndrome. These kits are developed and validated to detect IgG and IgM immunoglobulins against Receptor Binding Domain (RBD) of SARS-CoV-2 Spike protein (S protein) and Nucleocapsid protein (N Protein). Proteintech`s wide range of cytokine-specific ELISA kits are extensively validated using in-house developed, human cell-expressed cytokines.